bpc 157 synthagen laboratories review BPC-157, 500 mcg, 60 Capsules Bpc157 testimonial | Synthagen laboratories

Montagna P, Capellino S, Villaggio B, Remorgida V, Ragni N, Cutolo M, et al

TB-500 upregulates VEGF and actin-binding proteins to initiate new capillary formation, while BPC-157 stabilises and organises the resulting vascular networks through its endothelial repair and VEGFR2 signalling activity

Originally developed by a research team at Washington State University in the United States, Dihexa is classified as an Angiotensin IV analog, yet it possesses a significantly more potent capacity for synaptogenesis (the formation of new synapses)

This profile distinguishes it from corticosteroids like prednisolone, which carry a broader range of potential systemic side effects including increased thirst, frequent urination and behavioral changes